Sunday , October 17 2021

Hepatic tumor is the tenth most common cancer in Chile and the fifth in the world




Hepatic tumors represent Chile's tenth "most frequent" cancer, while worldwide is the fifth deadly carcinoma, according to data collected in 2018 by the World Health Organization (WHO) and the International Agency for Research on Cancer (Globocan). These institutions found that this data, which represents 3.22% of the total of this disease, is 1,582 new cases, responsible for 1,448 deaths, 5% of the total deaths of cancer and a prevalence estimated at five years of 1,060 annual cases.

"Hepatocellular carcinoma is the tumor responsible for most liver cancersAmong the causes that are known to date, there is prolonged damage to the liver, such as the case of chronic hepatitis B or C virus infections, alcoholic cirrhosis, non-alcoholic steatohepatitis, or fatty liver in patients with resistance to insulin and others, "said the doctor, pathologist, molecular oncologist and CEO of the Clinic ReCell Center, Ramon Gutiérrez in conversation with Efe.

Gutiérrez maintained that the worrying is that estimates show that in Chile At least one quarter of the adult population suffers from non-alcoholic fatty liver and this disease is in the origin of about 15% of cases of liver cancer. On the other hand, about 5% of patients suffering from cirrhosis develop this type of cancer.

"The biggest problem with liver cancer is that it is a silent disease Given its asymptomatic characteristic, which usually results in advanced stages when the possibilities of effective treatment are lower, "Gutiérrez emphasized in statements to Efe, who is also the president of the Chilean Society of Dendritic Cell Immunotherapy and exosomes (SOCHIDEX). However, he stressed, there are several treatments that can be accessed depending on the patient's condition, size of the tumor, among other factors.

among the traditional treatments There is surgery, chemotherapy and radiotherapy, which are complementary therapies that They contribute to a better evolution of the patient And they help to boost up to 40% the results of traditional treatments, even in some cases of cancer in more advanced stages, the only option. "Third-generation dendritic cell immunotherapy treatments use techniques with one of the most personalized and specific protocols since they are developed for each patient and are capable of stimulating the immune system, recognizing and destroying the Tumor cells, and deliver new hope to patients, "the doctor added.

"All this allows in some types of cancer lIn order to reduce the reappearance of the disease, up to 70% decrease, Reduce up to 80% the intensity of clinical complications derived from the tumor; improve the quality of life and extend the overall survival, bearing in mind that being a biological therapy, the same protocol can evolve differently in each person, "added the expert. Dr. Gutiérrez pointed out that excessive consumption of unhealthy foods, alcohol intake, insulin resistance, sedentary lifestyle, aflatoxin poisoning, and others, result in the emergence of new cases and the development of cancer in the liver.

Gutiérrez, also explained that Although the disease is more frequent in men, in women, there has been an increase in the number of cases, "Especially after 50 years."


Source link